Hollsteen
← IBM

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 2016: $1.5B · 10-Q 0000051143-16-000013 filed Apr 26, 2016Research and development · Q2 2016: $1.5B · 10-Q 0001104659-16-134367 filed Jul 26, 2016Research and development · Q3 2016: $1.4B · 10-Q 0001104659-16-151931 filed Oct 25, 2016Research and development · Q4 2016: $1.4B · derived · 10-K 0001047469-18-001117 filed Feb 27, 2018Research and development · Q1 2017: $1.5B · 10-Q 0001104659-18-026178 filed Apr 24, 2018Research and development · Q2 2017: $1.4B · 10-Q 0001104659-18-048404 filed Jul 31, 2018Research and development · Q3 2017: $1.3B · 10-Q 0001104659-18-064673 filed Oct 30, 2018Research and development · Q4 2017: $1.4B · derived · 10-K 0001047469-19-000712 filed Feb 26, 2019Research and development · Q1 2018: $1.4B · 10-Q 0001104659-18-026178 filed Apr 24, 2018Research and development · Q2 2018: $1.4B · 10-Q 0001104659-18-048404 filed Jul 31, 2018Research and development · Q3 2018: $1.3B · 10-Q 0001104659-18-064673 filed Oct 30, 2018Research and development · Q4 2018: $1.4B · derived · 10-K 0001558370-20-001334 filed Feb 25, 2020Research and development · Q1 2019: $1.4B · 10-Q 0001104659-19-025328 filed Apr 30, 2019Research and development · Q2 2019: $1.4B · 10-Q 0001558370-19-006560 filed Jul 30, 2019Research and development · Q3 2019: $1.6B · 10-Q 0001558370-19-009324 filed Oct 30, 2019Research and development · Q4 2019: $1.6B · derived · 10-K 0001558370-21-001489 filed Feb 23, 2021Research and development · Q1 2020: $1.6B · 10-Q 0001558370-20-004491 filed Apr 28, 2020Research and development · Q2 2020: $1.6B · 10-Q 0001558370-20-008516 filed Jul 28, 2020Research and development · Q3 2020: $1.5B · 10-Q 0001558370-20-011799 filed Oct 27, 2020Research and development · Q4 2020: $1.5B · derived · 10-K 0001558370-22-001584 filed Feb 22, 2022Research and development · Q1 2021: $1.6B · 10-Q 0001558370-22-005983 filed Apr 26, 2022Research and development · Q2 2021: $1.6B · 10-Q 0001558370-22-010985 filed Jul 25, 2022Research and development · Q3 2021: $1.6B · 10-Q 0001558370-22-015322 filed Oct 25, 2022Research and development · Q4 2021: $1.6B · derived · 10-K 0001558370-23-002376 filed Feb 28, 2023Research and development · Q1 2022: $1.7B · 10-Q 0001558370-22-005983 filed Apr 26, 2022Research and development · Q2 2022: $1.7B · 10-Q 0001558370-22-010985 filed Jul 25, 2022Research and development · Q3 2022: $1.6B · 10-Q 0001558370-22-015322 filed Oct 25, 2022Research and development · Q4 2022: $1.6B · derived · 10-K 0000051143-24-000012 filed Feb 26, 2024Research and development · Q1 2023: $1.7B · 10-Q 0001558370-23-006656 filed Apr 25, 2023Research and development · Q2 2023: $1.7B · 10-Q 0000051143-23-000021 filed Jul 25, 2023Research and development · Q3 2023: $1.7B · 10-Q 0000051143-23-000032 filed Oct 31, 2023Research and development · Q4 2023: $1.7B · derived · 10-K 0000051143-25-000015 filed Feb 25, 2025Research and development · Q1 2024: $1.8B · 10-Q 0000051143-24-000025 filed Apr 30, 2024Research and development · Q2 2024: $1.8B · 10-Q 0000051143-24-000039 filed Jul 30, 2024Research and development · Q3 2024: $1.9B · 10-Q 0000051143-24-000049 filed Oct 30, 2024Research and development · Q4 2024: $2.0B · derived · 10-K 0000051143-26-000010 filed Feb 24, 2026Research and development · Q1 2025: $1.9B · 10-Q 0000051143-25-000032 filed Apr 24, 2025Research and development · Q2 2025: $2.1B · 10-Q 0000051143-25-000052 filed Jul 24, 2025Research and development · Q3 2025: $2.1B · 10-Q 0000051143-25-000064 filed Oct 23, 2025Research and development · Q4 2025: $2.2B · derived · 10-K 0000051143-26-000010 filed Feb 24, 2026Research and development · Q1 2026: $2.2B · 10-Q 0000051143-26-000038 filed Apr 23, 2026Research and development · Q2 2026: $2.3B · 10-Q 0000051143-26-000078 filed Jul 23, 20261,540a2,3111,458Q1 2016Q2 2026Q4 2020
$MResearch and development · Q4 2019: $1.6B · derived · 10-K 0001558370-21-001489 filed Feb 23, 2021Research and development · Q1 2020: $1.6B · 10-Q 0001558370-20-004491 filed Apr 28, 2020Research and development · Q2 2020: $1.6B · 10-Q 0001558370-20-008516 filed Jul 28, 2020Research and development · Q3 2020: $1.5B · 10-Q 0001558370-20-011799 filed Oct 27, 2020Research and development · Q4 2020: $1.5B · derived · 10-K 0001558370-22-001584 filed Feb 22, 2022Research and development · Q1 2021: $1.6B · 10-Q 0001558370-22-005983 filed Apr 26, 2022Research and development · Q2 2021: $1.6B · 10-Q 0001558370-22-010985 filed Jul 25, 2022Research and development · Q3 2021: $1.6B · 10-Q 0001558370-22-015322 filed Oct 25, 20221,540a1,6061,596aQ4 2019Q3 2021Q4 2020
Q4 2020
1,540a$M
derived
All values (42)
PeriodValue ($M)Status
Q2 20262,311reported
Q1 20262,173reported
Q4 20252,187derived
Q3 20252,082reported
Q2 20252,097reported
Q1 20251,950reported
Q4 20241,967derived
Q3 20241,876reported
Q2 20241,840reported
Q1 20241,796reported
Q4 20231,748derived
Q3 20231,685reported
Q2 20231,687reported
Q1 20231,655reported
Q4 20221,604derived
Q3 20221,611reported
Q2 20221,673reported
Q1 20221,679reported
Q4 20211,625derived
Q3 20211,606reported
Q2 20211,641reported
Q1 20211,616reported
Q4 20201,540derived
Q3 20201,515reported
Q2 20201,582reported
Q1 20201,625reported
Q4 20191,596derived
Q3 20191,553reported
Q2 20191,407reported
Q1 20191,433reported
Q4 20181,358derived
Q3 20181,252reported
Q2 20181,364reported
Q1 20181,405reported
Q4 20171,378derived
Q3 20171,291reported
Q2 20171,436reported
Q1 20171,484reported
Q4 20161,431derived
Q3 20161,397reported
Q2 20161,465reported
Q1 20161,458reported

CSV with all sources · Technical ID: rnd

More metrics for IBM

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$1.5B (derived)
Period
Q4 2020, ended Dec 31, 2020 · quarterly value (3 months, not cumulative)
Calculation
Q4 = fiscal year − 9 months cumulative = 6,262M − 4,722M = $1.5B (FY value from 10-K 0001558370-22-001584; 9-month value from the Q3-10-Q)
Source
10-K, filed Feb 22, 2022 · 0001558370-22-001584
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$1.5BFeb 22, 202210-K 0001558370-22-001584derived · confidence 1. · current